Pharmaceutical Articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

Woman sues metal hip implant maker for pain and suffering

Posted: May 19, 2013

Diana Jaras has a difficult time understanding what went wrong with her hip replacement. She was having problems with her hip and had to have her metal-on-metal Stryker implant replaced. She underwent revision surgery three months ago, and now walks

New study shows increased risk of autism in children exposed to SSRIs in utero

Posted: May 19, 2013

Children exposed to antidepressants in their mother’s womb are more likely to develop autism than children who were not exposed to the drugs, a new study suggests. The study identified the risk with both selective serotonin reuptake inhibitors (SSRIs) and

FDA rejects drug maker’s request to block generic versions of opioid painkiller

Posted: May 19, 2013

The Food and Drug Administration (FDA) has vowed to crack down on powerful opioid painkillers that are easily abused and misused; however, the agency this week voted to deny a request by drug maker Endo Health Solutions to block generic

Sleeping pills land more people in emergency room than ever before

Posted: May 18, 2013

The popular prescription sleep medication Ambien and others that contain the active ingredient zolpidem are sending an increasing number of people to the emergency room, a new study has found.

Children on dialysis living longer than in years past

Posted: May 17, 2013

Children on dialysis for end-stage kidney disease have a much lower risk of dying than they did 20 years ago, according to a new study published in the Journal of the American Medical Association (JAMA).

SSRI use during fertility treatments shows little benefit to mother or fetus

Posted: May 17, 2013

Depressed women taking selective serotonin reuptake inhibitors (SSRIs) who are also undergoing infertility treatment may be more likely not to conceive, to suffer complications with pregnancy, and to have a baby with birth defects, a new meta-analysis shows.

Drug company fined $500 million for impure manufacturing practices

Posted: May 16, 2013

Generic drug maker Ranbaxy Laboratories Limited was found guilty of violating the Federal Food, Drug & Cosmetic Act and ordered to pay $500 million in fines and civil penalties for selling impure drugs and lying about tests on the products

Victims of transvaginal mesh hold rally to raise awareness

Posted: May 16, 2013

Victims of transvaginal mesh rallied outside Saskatoon City Hospital in Canada this week to raise awareness of the dangerous side effects that can occur from surgical mesh used to treat common pelvic floor conditions including stress urinary incontinence and pelvic organ

Woman’s bone disease linked to Mirena IUD

Posted: May 16, 2013

A 33-year-old woman who used the Mirena Intrauterine Device (IUD) for birth control for about six months developed a serious bone disease that left her disabled. The Mirena IUD was considered the primary source of her condition, according to researchers

Newborn’s long list of birth defects blamed on antidepressant Zoloft

Posted: May 16, 2013

Use of the antidepressant Zoloft during pregnancy is considered the primary cause of a long list of serious birth defects in a newborn. The case was reported last year to the Food and Drug Administration (FDA) Adverse Event Reporting Program,